Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease based on Insurance Claims in the US
mediaposted on 2020-05-18, 15:46 authored by Amy L Olson, Toby M Maher, Valentina Acciai, Baher Mounir, Manuel Quaresma, Leila Zouad-Lejour, Christopher D Wells, Lou De Loureiro
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.